Introduction
Botulinum neurotoxins (BoNTs), produced by Clostridium botulinum, 1 are considered the most lethal substance known to humans. BoNTs are classified into seven immunologically distinct serotypes (A -G) each of which can cause flaccid muscle paralysis and subsequent death by blocking the release of neurotransmitters at neuromuscular junctions. Structurally, the neurotoxins are expressed a s a single chain polypeptide which after post-translational proteolysis consists of two subunits: a 100 kDa heavy chain (HC) and a 50 kDa light chain (LC) linked via a disulfide bond. The HC is responsible for the binding and translocation of the toxin acr oss the synaptic membrane through specific receptors; whereas the LC function as an active zinc-endopeptidase that cleaves the SNARE proteins (soluble N-ethylmaleimide -sensitive factor attachment protein receptor) leading to inhibition of acetylcholine release and subsequent neuroparalysis. 2 The neurotoxin can enter the body via the gastrointestinal tract or through mucous membranes of, for instance, the eyes or the respiratory tract. In human, a lethal dose intravenously is estimated at 1-2 ng/kg body weight, orally at 1 µg/kg and 10-12 ng/kg by inhalation. 3 The gold standard "mouse bioassay" is able to detect as little as 10 pg/ml of toxin, 4 however, it requires several days of assay time, large number of animals and can only be performed at specific laboratories. Therefore rapid, sensitive and easily accessible assays are required to meet biodefense diagnostic and therapeutic needs. A number of in vitro assays to detect BoNTs, including ELISA, 5 immuno-PCR, 6 surface plasmon resonance (SP R) immunoassay 7 and electrochemical luminescence 8 have been developed. 9 However, these assays usually do not provide information on the enzymatic activity that is responsible for the toxicity of BoNTs. By rational design of a peptide substrate containing the BoNTs cleavage site derived from the SNARE protein, it is possible to monitor the activity of various serotypes of BoNTs as each serotype cleaves at different sites of the SNARE protein. Assays to monitor the activity of BoNTs are typically based on measuring the mass changes after the cleavage of the substrate via SP R; 10 counting the number of amplifier or labels such as phages-based amplifier, 11 or monitoring the reduction in the fluorescence resonance energy transfer (FRET) upon the cleavage of substrates. 12 Among these methods FRET has been extensively applied for monitoring proteolytic activities of various proteases including trypsin, caspase 1, caspase 3, thrombin, chymotrypsin, collagenase, HIV-1 protease and so on. 13 Several of the organic fluorophores commonly used in FRET bioassays suffer from pH sensitivity, photo-bleaching, chemical degradation and absorption spectra overlapping between the acceptor and donor. To address these problems, quantum dots (QDs) have been employed in FRET because of their relative stability, tuneable emissions for optimizations of the spectra overlap with a particular acceptor , and potential minimization of the direct acceptor excitation.
nanoparticles smaller than 40 nm in diameter, the absorption term dominates over scattering, and radiative quenching becomes the main cause for energy transfer from the dye to the metal which results in electron-hole pair formations and subsequent Ohmic losses. 15a On the contrary, large nanoparticles are expected to enhance the fluorescence because scattering dominates over absorption. Au nanoparticles have been reported previously as quenching beacons for the detection of DNA, RNA, protease and other biomolecules.
In this paper, Au nanoparticles with diameter of 1.4 nm, 6 nm and 18 nm were modified with peptides containing a BoLcA cleavage site (AuNP-pep) and employed as radiative quenchers for monitoring the activity of BoLcA. The AuNPpep construct was pretreated with BoLcA prior to the incubation with the streptavidin-Alexa 488 conjugate (SA488) for the measurement of the fluorescence intensity. The fluorescence of SA488 recovered upon cleavage of the peptides on the AuNPs in the presence of BoLcA, Fig. 1 . The fluorescence energy transfer efficiency was then investigated for AuNPs of different sizes. Finally, the time -resolved catalytic activity of BoLcA on AuNP-pep constructs was monitored and compared with the activity of trypsin on the same AuNP-pep construct. 
Results and discussion

Peptide sequence
Previous research has reported that a short peptide derived from the C-terminal end (187-203) of the SNAP-25 protein can be hydrolyzed by BoNT at a similar rate as the full length SNAP-25, as long as the peptide has a minimum length of 14 to 16 amino acids and that arginine is present at the cleavage site. 16 The peptide sequence used in our study was designed based on the 17 amino acids at the Cterminus of SNAP-25 protein (187-203). The glutamine-arginine (Q-R) located in the middle of the target peptide is the cleavage site for BoLcA proteolysis according to mass spectrometer results (Fig. S1 †) and previous work. [16] [17] Further, substitution of methionine (M) in position 202 with norleucine (X) increases the proteolytic rate of BoLcA. 16, 18 At the N-terminus of the peptide a cysteine was attached to enable the immobilization on AuNPs via the -SH moiety. In addition, an 11 unit ethylene glycol oligomer was introduced as a spacer between Cys and the recognition sequence to minimize the steric hindrance caused by AuNPs. At the C-teriminus a biotin molecule was added for the specific interaction with the streptavidindye conjugate.
AuNPs size-dependent energy transfer efficiency
The peptide was attached to AuNPs with sizes of 1. (Fig. 2C ). The maximum fluorescence quenching efficiency was observed for a AuNP-pep/SA488 ratio of ~5 which is reasonable given that streptavidin has 4 affinity binding sites for biotins. Previous work suggests that small AuNPs with the diameter of ~1-3 nm as an acceptor can be described by the nanometal surface energy transfer (NSET) theory. 15a In contrast to FRET, NSET does not require a resonant electronic transition as it originates from the interaction of the electromagnetic field of the donor dipole with the free conduction electrons of the accepting metal. The NSET characteristic distance R 0 is expressed as
where Φ D is the donor quantum efficiency, ω is the frequency of the donor electronic transition, ω f and k f are the Fermi frequency and Fermi wavevector of Au, respectively. In general, the fluorescence quenching efficiency E can be expressed as a function of the donor/acceptor distance, R, as
where n = 6 for FRET and n = 4 for NSET. 2)) is plotted in Fig. 2D , from which the distance between the dye and AuNPs was estimated as R = 6.85 nm in the case of 1.4 nm AuNP-pep constructs based on NSET. The distance is shorter than the linear extension length of the peptide L ~ 8 nm. Therefore, we anticipate that a partially bended or folded peptide structure should be considered. As compared with 1.4 nm AuNPs, the larger AuNPs, with diameter of 6 nm and 18 nm, displayed an increasing fluorescence quenching efficiency (Fig. 2C) . The fluorescence quenching efficiency for 6 nm and 18 nm AuNPs reached a maximum at around 90% and 98% for molar ratios of 3:1 and 1:3, respectively. This is reasonable as the large AuNPs offer higher extinction coefficient and carry a larger number of peptide on the AuNP. The average number of peptides on each 18 nm and 6 nm AuNPs was estimated to be 51 and 3, respectively. This calculation is based on peptide/thiol-PEG molar ratio of 1:100 (18 nm AuNPs) and 0.5:100 (6 nm AuNPs) and the assumption that each thiol occupies an area of 0.2 nm 2 . These observations suggest that the fluorescence quenching efficiency is determined by both the size of the AuNPs, and the coverage of peptides on the AuNPs. The fluorescence quenching efficiency reached the maximum at a relatively lower AuNP-pep/SA488 ratio when increasing the coverage of peptide on 6 nm AuNPs (Fig. S3 †) . Furthermore, the energy transfer for large AuNPs with diameter of 6 nm and 18 nm were assumed to be dominated by FRET, from which the characteristic radius (R 0 ) is estimated as R 0 = 16.6 and 29.8 nm, respectively (see ESI †). Accordingly, based on the calculation that the distance between the dye and the AuNPs surface is about R = 6.85 nm, we estimate a quenching efficiency of E~95% and 98% for the 6 and 18 nm AuNPs, respectively (Eq. (2)). These values are consistent with the maximum fluorescence quenching efficiencies of E=92% and 98% for the 6 and 18 nm AuNPs, respectively, as presented in Fig. 2C . Thus, our results confirm that the energy transfer on AuNPs with a diameter larger than 6 nm follows the FRET mechanism. 
AuNPs size-dependent protease activity
The BoLcA activity was monitored through time-dependent fluorescence spectra of SA488 incubated with 1.4 nm AuNP-peps which were pre-treated with BoLcA for 30 min up to 6 hours (Fig.  3A) . The fluorescence intensity at the emission wavelength of 520 nm increased from 2. estimated to equal K M = 643 µM, which is comparable to that of the free peptide. 16 The poorer activity of BoLcA for the peptide on large
AuNPs is ascribed to the fact that the active pocket of BoLcA is deeply buried inside the enzyme (~2.4 nm) 20 , and steric hindrance induced by the AuNPs. A similar phenomenon was also observed for trypsin and the same AuNP-pep. The catalytic rate of trypsin is higher on small AuNPs than on large AuNPs as indicated in Fig. 3C . The cleavage percentage was defined as ΔF/(F SA488 -F 0 ), where F SA488 and F 0 are the fluorescence intensities of free SA488 and AuNP-pep-SA488 conjugates measured at λ=520 nm, respectively. The results indicated that about 90% of peptides on AuNPs were hydrolyzed by trypsin in 1, 4 and 10 hours for 1.4 nm, 6 nm and 18 nm AuNP-pep, respectively. As compared with BoLcA (Fig. 3B) that reported for four-residue peptide substrates containing an arginine cleavage site. 22 The trypsin proteolytic activity is about 29 times higher than that of BoLcA. Furthermore, upon increasing the size of AuNPs from 1.4 nm to 18 nm in diameter, the trypsin activity was decreased 18 fold, a decrease that is 4 times smaller as compared with the 80-fold decrease for BoLcA (Fig. 3D) . Again the poor catalytic activity of BoLcA and more significant hindrance by large AuNPs might be ascribed to the deeper active pocket sites and 2-fold higher molecular weight of BoLcA as compared to trypsin, as 
BoLcA sensing
Considering the situation that the large AuNPs significantly hindered the accessibility of BoLcA to the peptides on the surface, we employed the smallest AuNPs (i.e. 1.4 nm in diameter) for the detection of BoLcA. The time-dependent fluorescence intensity of SA488 was monitored after incubation with AuNP-pep which was pre-treated with BoLcA at various concentrations from 1 pM to 10 nM at 37 ºC (Fig. 4A) . The fluorescence intensity saturated quickly after 2 hours incubation of AuNP-pep with BoLcA at concentrations higher than 3 nM (Fig. 4A) . However, at low concentration of BoLcA (< 3nM), the fluorescence intensity increased approximately at a near linear speed after 2 hours incubation. It is interesting to notice that at concentrations of BoLcA lower than 3 nM the fluorescence intensity decreased in the first reaction hour (see insert in Fig. 4A ). This might be ascribed to a transient conformational change (bending) of the peptide upon its affinity interactions with BoLcA prior to its cleavage (Fig. 1) . The BoLcA interaction with the peptide was considered to two sub-processes: an affinity binding step to form the intermediate ES complex, and a proteolysis step (see ESI †). As these two processes occur simultaneously , the initial fluorescence decrease was compensated by the recovery of fluorescence from the cleavage of peptides. This phenomenon was not observed in trypsin because of its high catalytic rate and its less deep cleavage sites as compared with BoLcA. The higher catalytic rate of trypsin is indicated in Fig. 4A , where the same amount of trypsin, such as 1 nM and 10 pM, provided about 10 folds higher response than BoLcA. However, to observe and confirm the peptide conformational changes, require single-molecule measurements. The calibration curve for the BoLcA from 1 pM to 10 nM reveals a limit of detection (LOD) of 1 pM (50 pg/ml), which is determined as the concentration of BoLcA at which the fluorescence intensity changes ΔF is three times of the standard deviation of the fluorescence fluctuation of control samples, i.e. 3×δF=1000 cps/µA. The method provided sensitive detection of BoLcA with the assay time of 2-3 hours which is comparable to the vesicle amplified SPR sandwich assay (LOD ~0.3 to 10 pM and assay time from 10 min to several hours) 10 , aptamber-based electrochemical assay (LOD of 40 pg/ml and assay time of 24 h) 23 , and the antibody-based SPR sandwich assay on the detection of BoNT Type B in buffer and honey (LOD~ 2 pM and assay time of 1-2 h) 7 . The LOD is about 2 to 3 orders of magnitude lower than the quantum dots based FRET method (LOD ~ 350 pM and assay time of 2-3 h) 24 , antibody-based ELISA (LOD of 0.2-2 ng/ml and assay time of 8 h) 5 . But it is less sensitive than mouse lethality assay (LOD of 20-30 pg/ml and assay time of 2-4 days) 25 . However, our method typically provides shorter assay time than conventional ELISA and mouse lethality assay, it is expected to be more robust assay as compared with the antibodybased assays.
Conclusion
We have designed and synthesized a substrate peptide, which was immobilized on AuNPs with diameter of 1.4-18 nm for the detection of BoLcA using a fluorescence energy transfer assay format. The results indicated that large AuNPs provided higher quenching efficiency, but significantly hindered the accessibility of BoLcA to the peptides on the AuNPs surface thus leading to an 80-fold lower initial catalytic rate of BoLcA. In addition, the time-resolved fluorescence measurement indicated the peptide potentially changes conformation (bends) upon affinity interaction with BoLcA. The assay provided limit of detection (LOD) of 1 pM for the detection of BoLcA with the assay time of 2-3 hours which was faster and more sensitive than many other assays including conventional ELISA. The proposed assay based on synthetic peptide is also more robust than antibody-based assay.
